Guo J, Yan X M, McLachlan S M, Rapoport B
Autoimmune Disease Unit, Cedars-Sinai Research Institute, and University of California School of Medicine, Los Angeles, CA 90048, USA.
J Immunol. 2001 Jan 15;166(2):1327-33. doi: 10.4049/jimmunol.166.2.1327.
Autoantibodies to thyroid peroxidase (TPO) are the hallmark of the humoral autoimmune response in human autoimmune thyroiditis (Hashimoto's thyroiditis). The majority of TPO autoantibodies in individual patients' sera interact with a restricted immunodominant region on TPO. Although this region can be mapped, previous studies have failed to localize its position on the TPO molecule. We, therefore, used a footprinting approach that can localize a highly conformational, discontinuous epitope on a very large molecule. Extensive biotinylation ( approximately 15 biotins/molecule protein) of lysine residues on the surface of purified, native TPO resulted in loss of multiple tryptic cleavage sites, as determined by analysis of tryptic polypeptide fragments on reverse-phase HPLC. TPO was then complexed with a monoclonal human autoantibody Fab (TR1.9) before biotinylation. After dissociation from TR1.9, TPO was recovered by gel filtration. A trypsin site, previously observed to be lost after TPO biotinylation, was restored when biotinylation was performed on the TPO-TR1.9 complex. The epitope-protected lysine (K) was present in a 30-aa TPO fragment that, by N-terminal sequencing, was found to be K713. Altered recognition by TR1.9 of a TPO-myeloperoxidase chimeric molecule involving this region supported the epitope protection data. In conclusion, we provide the first identification of an amino acid residue (K713) comprising part of an epitope within the TPO immunodominant region. This focal residue localizes the facet on the large, highly complex TPO molecule that contains the immunodominant region and provides the basis for rational guided mutagenesis studies to more fully characterize this region.
甲状腺过氧化物酶(TPO)自身抗体是人类自身免疫性甲状腺炎(桥本甲状腺炎)体液自身免疫反应的标志。个体患者血清中的大多数TPO自身抗体与TPO上一个有限的免疫显性区域相互作用。尽管该区域可以定位,但先前的研究未能确定其在TPO分子上的位置。因此,我们采用了一种足迹法,该方法可以在一个非常大的分子上定位一个高度构象性的、不连续的表位。对纯化的天然TPO表面的赖氨酸残基进行广泛的生物素化(约15个生物素/分子蛋白),通过反相高效液相色谱分析胰蛋白酶多肽片段,结果显示多个胰蛋白酶切割位点丢失。然后在生物素化之前,将TPO与单克隆人自身抗体Fab(TR1.9)复合。从TR1.9解离后,通过凝胶过滤回收TPO。当对TPO-TR1.9复合物进行生物素化时,先前在TPO生物素化后观察到丢失的一个胰蛋白酶位点得以恢复。表位保护的赖氨酸(K)存在于一个30个氨基酸的TPO片段中,通过N端测序发现该片段为K713。涉及该区域的TPO-髓过氧化物酶嵌合分子对TR1.9的识别改变支持了表位保护数据。总之,我们首次鉴定出一个氨基酸残基(K713),它是TPO免疫显性区域内一个表位的一部分。这个关键残基在大的、高度复杂的TPO分子上定位了包含免疫显性区域的小平面,并为更全面地表征该区域的合理导向诱变研究提供了基础。